Feedback
  • Log In
  • Account Access
  • Contact Us

    Pre-Sales Support

    Mutual Funds and ETFs - 800-456-7526
    Monday-Thursday: 8:00 a.m. – 6:00 p.m. ET
    Friday: 8:00 a.m. – 5:00 p.m. ET

    ETF Trading Support - 415-315-6600
    Monday-Friday: 9:30 a.m. – 5:00 p.m. ET

    Post-Sales and Website Support
    888-843-7824
    Monday-Friday: 9:00 a.m. - 6:00 p.m. ET

Hartford Healthcare HLS Fund

Explore Another ETFs

Objective

Seeks long-term growth of capital.

Overview

A stock fund that invests in health care, a sector that is experiencing innovations and breakthroughs across multiple subsectors.

More About Healthcare HLS Fund 

Performance

Performance (%)
% (as of 12/31/2017)
Average Annual Total Returns % (as of 12/31/2017)
YTD 1YR 3YR 5YR 10YR SI
Hartford Healthcare HLS  IA 22.26 22.26 8.24 19.66 12.13 12.34
Benchmark 22.47 22.47 8.82 17.98 11.36 ---
Morningstar Health Category 24.34 24.34 6.30 17.92 11.75 ---
Performance (%)
% (as of 12/31/2017)
Average Annual Total Returns % (as of 12/31/2017)
YTD 1YR 3YR 5YR 10YR SI
Hartford Healthcare HLS  IA 22.26 22.26 8.24 19.66 12.13 12.34
Benchmark 22.47 22.47 8.82 17.98 11.36 ---
Morningstar Health Category 24.34 24.34 6.30 17.92 11.75 ---
SI = Since Inception. Fund Inception: 05/01/2000
Operating Expenses:   Net  0.89% |  Gross  0.89%

Performance data quoted represents past performance and does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted.

Prior to 4/1/2016, the Fund's benchmark was the S&P North American Health Care Sector Index.

Calendar Year Returns (%)
Fund Benchmark
2017 22.26 22.47
2016 -8.39 -2.05
2015 13.21 7.41
2014 27.39 24.79
2013 51.84 42.19
2012 20.62 18.35
2011 8.54 11.88
2010 7.10 5.20
2009 22.72 20.76
2008 -25.56 -23.76

Excludes sales charges. If sales charges and taxes had been included, the value would have been lower.

Characteristics Holdings are subject to change. Percentages may be rounded.

Statistics
As of Date 12/31/2017
Net Assets $335 million
# of Holdings 99
Beta 1.19
R Squared 0.92
% in Equities 98%
Turnover (12/31/2017) 18%
% in Foreign Equities 12%
Standard Deviation 15.78%
Holdings Characteristics
(as of 12/31/2017)
Fund S&P Composite 1500 Health Care Index
Asset Weighted Market Cap $54.0 billion $120.1 billion
EPS Growth Rate 21.7% 11.6%
Price/Book 3.4x 4.0x
Price/Earnings 33.8x 16.7x
Return on Equity 3.8% 22.1%

Subsector Exposure

(as of 12/31/2017)
label currentpercentage
Biopharma Mid Cap 17%
Biopharma Small Cap 9%
Health Care Services 24%
Medical Technology 26%
Biopharma Large Cap 24%
(as of 9/30/2017)
label currentpercentage
Biopharma Mid Cap 18%
Biopharma Small Cap 9%
Health Care Services 24%
Medical Technology 24%
Biopharma Large Cap 25%

Based on sub-adviser’s classification of health care subsectors, which includes combining biotechnology and pharmaceuticals in terms of capitalization: biopharma small-cap, biopharma mid-cap, and biopharma large-cap. Excludes cash. May not total to 100% due to rounding.

Top Holdings

(as of 12/31/2017)
label percentageholding
UnitedHealth Group, Inc. 6.40
Medtronic plc 4.79
Bristol-Myers Squibb Co. 4.29
Allergan plc 3.37
Celgene Corp. 3.15
Stryker Corp. 2.89
Eli Lilly & Co. 2.88
Boston Scientific Corp. 2.85
Thermo Fisher Scientific, Inc. 2.59
AstraZeneca plc 2.58
Total Portfolio % 35.79
(as of 9/30/2017)
label percentageholding
UnitedHealth Group, Inc. 6.03
Medtronic plc 4.53
Bristol-Myers Squibb Co. 4.39
Celgene Corp. 4.33
Allergan plc 3.68
Boston Scientific Corp. 3.08
Eli Lilly & Co. 2.87
Stryker Corp. 2.61
Thermo Fisher Scientific, Inc. 2.54
AstraZeneca plc 2.47
Total Portfolio % 36.53
Market Cap Distribution %
(as of 12/31/2017)
Less than $2 billion 13.5
$2 billion - $5 billion 8.9
$5 billion - $10 billion 6.3
Greater than $10 billion 71.3
Fund Essentials
Inception Date 05/01/2000
Symbol HIAHX
CUSIP 416528719
Fund Number 2055

Insights

pdf

2018 Outlooks (Schroders) 

Fri Dec 22 14:06:00 EST 2017
Thought leaders from Schroder Investment Management provide their outlook on issues that may influence markets and portfolios going forward.
pdf

1Q 2018 Outlooks (Wellington) 

Thu Dec 21 14:06:00 EST 2017
Thought leaders from Wellington Management provide their outlook on issues that may influence markets and portfolios going forward.
pdf

Correlation and Dispersion: Return of the Stock Picker's Market? 

Tue Jun 06 10:00:00 EDT 2017
Amid normalizing central bank policy, correlations and dispersion are trending in a favorable direction for fundamental investors.

Literature

Fund Literature

Select All

Fact Sheet

09/30/2017 | pdf

Max 100

Commentary

09/30/2017 | pdf
Get FINRA Letter

Max 100

Summary Prospectus

05/01/2017 | pdf

Available For
Download Only

Semi Annual Report

06/30/2017 | pdf

Available For
Download Only

Statutory Prospectus

05/01/2017 | pdf

Available For
Download Only

Annual Report

12/31/2016 | pdf

Available For
Download Only

SAI

05/01/2017 | pdf

Available For
Download Only

Financial Professionals:

Log in to order forms and literature and manage your subscriptions.

A WORD ABOUT RISK

All investments are subject to risk, including the possible loss of principal. There is no guarantee the Fund will achieve its stated objective. The Fund's share price may fluctuate due to market risk and/or security selections that may underperform the market or relevant benchmarks. Risks of focusing investments on the healthcare related sector include regulatory and legal developments, patent considerations, intense competitive pressures, rapid technological changes, potential product obsolescence, and liquidity risk. Foreign investments can be riskier than U.S. investments due to the adverse effects of currency exchange rates, differences in market structure and liquidity, as well as political and economic developments in foreign countries and regions (e.g., "Brexit"). These risks are generally greater for investments in emerging markets. Small- and mid-cap securities can have greater risk and volatility than large-cap securities.
 

Hartford HLS Funds are underwritten and distributed by Hartford Funds Distributors, LLC.

201329